Findings even true in adults younger than 40 years of age
FRIDAY, July 19, 2024 (HealthDay News) — Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the Journal of the American Heart Association.
Chance Strenth, Ph.D., from University of Texas Southwestern Medical Center Dallas, and colleagues assessed the prevalence of probable OSA and its relationship with cardiovascular risks and diseases. The analysis included data from 9,887 community-dwelling adults participating in the National Health and Nutrition Examination Survey (2013 to 2018).
The researchers found individuals with probable OSA had a significantly higher prevalence of health conditions, including hypertension (adjusted prevalence ratio [aPR], 1.19), diabetes (aPR, 1.17), metabolic syndrome (aPR, 1.14), heart attack (aPR, 1.63), stroke (aPR, 1.41), and any CVD event (aPR, 1.36) when adjusting for relevant factors. Young adults (ages 20 to 40 years) with probable OSA had higher prevalence rates of any CVD events (aPR, 3.44), hypertension (aPR, 1.45), metabolic syndrome (aPR, 1.25), and angina (aPR, 10.39).
“While cross-sectional, [the study] emphasizes that health care providers should recognize OSA as significantly associated with CVDs and its precursor risks in young adults, stressing proactive care and screening to reduce CVD risk in this population,” the authors write.
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians
Antenatal Complications Increased With Maternal Multiple Long-Term Conditions
Phthalates From Personal Care Products Tied to Higher BP in Pregnancy
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk
Review Reveals Limited Effects of Exercise on Hip Osteoarthritis